Prof. Solange Peters (Chair), Dr Anne-Marie Baird, Prof. Reinhard Büttner, and Dr Noemi Reguart, will discuss the importance of the implementation of biomarker testing in routine clinical practice and the current and future challenges associated with this practice.
Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine
		15 Jun 2022
		
		
	
	
	
		
			
	
				
				Oncology
			
		
	
		
		
		
			Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.




